Duke University Medical Center
Durham, North Carolina, 27710, United States
NCT Number: NCT02457715
This is a parallel group, single institution, prospective clinical study. The purpose of this study is to assess whether the Jawbone Up 24, a consumer based accelerometer, can be a feasible tool to study physical activity in cancer patients and patients with Amyotrophic Lateral Sclerosis (ALS).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Prostate cancer:
Renal cancer:
Brain cancer:
ALS patients who are:
Exclusion criteria
Time frame: 14 weeks
Time frame: 14 weeks
Time frame: 14 weeks
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00581815
Adnexal Diseases, Adrenal Cortical Cancer
New York, United States
View Trial DetailsNCT05366881
Adnexal Diseases, Bladder Cancer
Duarte, California, United States
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT04430842
Adenocarcinoma, Adenoma
Kogarah, New South Wales, Australia
View Trial Details